Momary KM - Search Results

1

Association of beta-blocker dose with serum procollagen concentrations and cardiac response to spironolactone in patients with heart failure.

Cavallari LH, Momary KM, Groo VL, Viana MA, Camp JR, Stamos TD. Cavallari LH, et al. Among authors: momary km. Pharmacotherapy. 2007 Jun;27(6):801-12. doi: 10.1592/phco.27.6.801. Pharmacotherapy. 2007. PMID: 17542763 Clinical Trial.

2

Racial differences in potassium response to spironolactone in heart failure.

Cavallari LH, Groo VL, Momary KM, Fontana D, Viana MA, Vaitkus P. Cavallari LH, et al. Among authors: momary km. Congest Heart Fail. 2006 Jul-Aug;12(4):200-5. doi: 10.1111/j.1527-5299.2006.05502.x. Congest Heart Fail. 2006. PMID: 16894278 Free article. Clinical Trial.

3

Markers of cardiac collagen turnover are similar in patients with mild and more severe symptoms of heart failure.

Cavallari LH, Groo VL, Momary KM, Stamos TD, Vaitkus PT. Cavallari LH, et al. Among authors: momary km. Congest Heart Fail. 2007 Sep-Oct;13(5):275-9. doi: 10.1111/j.1527-5299.2007.07217.x. Congest Heart Fail. 2007. PMID: 17917494 Free article.

4

Clopidogrel and proton pump inhibitors: between a rock and a hard place.

Momary K, Cavallari LH. Momary K, et al. Pharmacotherapy. 2010 Aug;30(8):762-5. doi: 10.1592/phco.30.8.762. Pharmacotherapy. 2010. PMID: 20653351 No abstract available.

5

Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke.

Momary KM, Shapiro NL, Brace LD, Shord SS, Grossi E, Viana MA, Helgason CM, Nutescu EA, Cavallari LH. Momary KM, et al. Cerebrovasc Dis. 2009;27(6):585-93. doi: 10.1159/000214223. Epub 2009 Apr 24. Cerebrovasc Dis. 2009. PMID: 19390185

6

Genomics and the efficacy of aspirin in the treatment of cerebrovascular disease.

Cavallari LH, Momary KM. Cavallari LH, et al. Among authors: momary km. Curr Treat Options Cardiovasc Med. 2009 Jun;11(3):191-200. doi: 10.1007/s11936-009-0020-x. Curr Treat Options Cardiovasc Med. 2009. PMID: 19433014

7

Pharmacogenomics of warfarin dose requirements in Hispanics.

Cavallari LH, Momary KM, Patel SR, Shapiro NL, Nutescu E, Viana MA. Cavallari LH, et al. Among authors: momary km. Blood Cells Mol Dis. 2011 Feb 15;46(2):147-50. doi: 10.1016/j.bcmd.2010.11.005. Epub 2010 Dec 24. Blood Cells Mol Dis. 2011. PMID: 21185752

8

Predictors of unstable anticoagulation in African Americans.

Cavallari LH, Aston JL, Momary KM, Shapiro NL, Patel SR, Nutescu EA. Cavallari LH, et al. Among authors: momary km. J Thromb Thrombolysis. 2009 May;27(4):430-7. doi: 10.1007/s11239-008-0236-8. Epub 2008 Jun 19. J Thromb Thrombolysis. 2009. PMID: 18563532

9

Genetic and clinical predictors of warfarin dose requirements in African Americans.

Cavallari LH, Langaee TY, Momary KM, Shapiro NL, Nutescu EA, Coty WA, Viana MA, Patel SR, Johnson JA. Cavallari LH, et al. Among authors: momary km. Clin Pharmacol Ther. 2010 Apr;87(4):459-64. doi: 10.1038/clpt.2009.223. Epub 2010 Jan 13. Clin Pharmacol Ther. 2010. PMID: 20072124

10

Cytochrome P450 2C9 mediated metabolism in people with and without cancer.

Shord SS, Cavallari LH, Viana MA, Momary K, Neceskas J, Molokie RE, Deyo K, Patel SR. Shord SS, et al. Int J Clin Pharmacol Ther. 2008 Jul;46(7):365-74. doi: 10.5414/cpp46365. Int J Clin Pharmacol Ther. 2008. PMID: 18793590 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters